SKDTY Stock DD Sky Deutschland AG 08/28/2014 19:43:02

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
SKDTY Sky Deutschland AG $SKDTY Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=SKDTY&am...mp;yt0=Go!

Last Updated: 08/28/2014 19:42:58

Current Price and Quotes
Last Price 8.80
Previous Close 8.835 Open 8.83
Daily Range N/A - 8.83 52wk Range 8.00 - 11.29
Volume 8,748 Dividend N/A
Average Vol (30d) 9,548 Yield N/A




Financials
Period Ending
Total Revenue
Cost of Revenue
Gross Profit
Operating Expenses

Research and Development
Sales, General and Admin.
Non-Recurring Items
Other
Operating Income
Income From Continuing Operations

Add'l Income/Expense Items
Earnings Before Interest and Tax
Interest Expense
Earnings Before Tax
Income Tax
Minority Interest
Equity Earnings Unconsolidated Subsidiary
Net Income Cont. Operations
Non Recurring Events

Discontinued Operations
Extraordinary Items
Effect of Accounting Changes
Other Items
Net Income
Preferred Stock and Other Adjustments
Net Income Applicable to Common Shareholders
Recent News

Aug 12, 2014 Parks Associates to Address the Competitive Pressure for the Smart Home and Entertainment Industries at CONNECTIONS(TM) Europe
Aug 6, 2014 Sky Deutschland Preliminary Results
Jun 6, 2014 ViXS XCode 6400 Powers World's First 4K Ultra HD Live Broadcast by Sky Deutschland
Jun 4, 2014 Groupe Média TFO, first french-language Canadian broadcaster to be nominated at IBC 2014 Innovation Awards
Jun 4, 2014 INSIDE Secure Protects Premium Content for Snap, Sky Deutschland's Online Media Application



SKDTY Sky Deutschland AG Research DD Guide

Stock Message Board http://investorshangout.com/search?q=SKDTY&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/SKDTY/quote
Stock Chart http://www.otcmarkets.com/stock/SKDTY/chart
Company Info http://www.otcmarkets.com/stock/SKDTY/company-info
Recent News http://www.otcmarkets.com/stock/SKDTY/news
Financials http://www.otcmarkets.com/stock/SKDTY/financials
Filings and Disclosure http://www.otcmarkets.com/stock/SKDTY/filings
Short Sales http://www.otcmarkets.com/stock/SKDTY/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/SKDTY/insider-transactions
Research Reports http://www.otcmarkets.com/stock/SKDTY/research
Summary http://finance.yahoo.com/q?s=SKDTY
Historical Prices http://finance.yahoo.com/q/hp?s=SKDTY+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=SKDTY
Basic Chart http://finance.yahoo.com/q/bc?s=SKDTY+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=SKDTY+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=SKDTY+Headlines
Press Releases http://finance.yahoo.com/q/p?s=SKDTY+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=SKDTY+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=SKDTY+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=SKDTY+Industry
Major Holders http://finance.yahoo.com/q/mh?s=SKDTY+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=SKDTY+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=SKDTY+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=SKDTY
Balance Sheet http://finance.yahoo.com/q/bs?s=SKDTY
Cash Flow http://finance.yahoo.com/q/cf?s=SKDTY+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/SKDTY
Market Watch http://www.marketwatch.com/investing/stock/SKDTY
Bloomberg http://www.bloomberg.com/quote/SKDTY:US
Morningstar http://quotes.morningstar.com/stock/s?t=SKDTY
Bussinessweek http://investing.businessweek.com/research/st...cker=SKDTY
Barchart http://www.barchart.com/quotes/stocks/SKDTY
OTC Short Report http://otcshortreport.com/index.php?index=SKDTY
Investopedia http://www.investopedia.com/markets/stocks/SKDTY/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

FDA Greenlights Kisqali®: A Major Step for Breast Cancer Care

Updated Category News Views 203

Kisqali® Receives FDA Approval for Early Breast Cancer Treatment Novartis has some exciting news for oncology: the US Food and Drug Administration (FDA) has officially approved Kisqali® (ribociclib) as a treatment for patients diagnosed with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) stage II and III early breast cancer...

Continue Reading
Ålandsbanken Abp Launches SEK 350M Additional Tier 1 Notes Series

Updated Category News Views 162

Ålandsbanken Abp Issues SEK 350,000,000 Additional Tier 1 Notes Ålandsbanken Abp, a prominent player in the banking industry, recently made waves in the financial market by issuing Additional Tier 1 floating rate notes amounting to SEK 350,000,000. The issuance marks a significant step in Ålandsbanken's strategic move to strengthen its capital position and enhance its...

Continue Reading
Harbour BioMed's 2025 Achievements and Future Prospects

Updated Category News Views 249

Harbour BioMed Achieves Significant Milestones in Interim Results Harbour BioMed (HKEX: 02142) is a prominent biopharmaceutical company focused on developing innovative antibody therapeutics, particularly in the fields of immunology and oncology. The company shared its impressive interim results for the first half of the year, showcasing remarkable growth and strategic...

Continue Reading
Innovative Investment Fuels Okika Devices' Future Growth Strategy

Updated Category News Views 187

Strategic Investment Boosts Okika Devices Advancement Colorado ONE Fund, which is part of the ONE Funds initiative, has made a major investment in Okika Devices, a company recognized for its innovation in Field Programmable Analog Array (FPAA) technology. This investment aligns with Colorado ONE Fund's mission to support technologies that advance the local innovation...

Continue Reading
Investors Take Note: Legal Options for Shareholders Explored

Updated Category News Views 61

Exploring Legal Options for Investors in Major Companies In recent developments, Halper Sadeh LLC, a reputable law firm focusing on investor rights, is carefully examining three significant companies for potential violations of federal securities laws. This investigation centers around the actions and decisions made by these firms, which may affect shareholders' rights...

Continue Reading